Galectin Therapeutics Inc. (GALT) stock surges during pre-market trading. Here’s what you should know?
Galectin Therapeutics Inc. (NASDAQ: GALT) stock declined by 15.24% at the last close whereas the GALT stock price gains by 10.07% in the pre-market trading session. Galectin Therapeutics is devoted to the development of new medicines to help people with chronic liver disease and cancer live better lives. >> 7 Top Picks for the Post-Pandemic […]
